Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DESVENLAFAXINE
- Effects of Paroxetine on Cardiovascular Function in Septic Patients
- A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
- Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression
- Study of Desvenlafaxine in Treating Major Depressive Disorder.
- A Relative Bioavailability Food Effect Study of LY03005
- A Study of LY03005 vs Pristiq
- Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®
- Pilot BA Study of New LY03005 vs Pristiq
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment
- Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
- Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
- Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury
- Desvenlafaxine in Opioid-Dependent Patients
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder
- Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities
- Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression
- Desvenlafaxine Monotherapy in Dysthymia
- Omega 3 FA Supplements as Augmentation in the Treatment of Depression
- Desvenlafaxine vs. Placebo Treatment of Chronic Depression
- Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine
- Effect of Antidepressants on White Matter Structure
- Neurocognition and Work Productivity in Major Depressive Disorder (MDD)
- Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
- A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
- Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
- 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder
- Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder
- Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)
- Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects
- Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)
- Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers
- Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)
- Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
- Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam
- Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women
- Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
- Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder
- Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)
- Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
- Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder
- Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects
- A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia
- Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women
- Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
- Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway
- Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder
- Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD
- Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)
- Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome
- Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women
- The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms
- Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder
- Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
- Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects
- Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
- Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
- Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy
- Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder
- Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause
Clinical trials list
click for details